Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 68,202 | 77,809 | 83,214 | 35,520 | 33,250 |
| Cost of Goods | 63,885 | 73,181 | 74,115 | 29,895 | 27,524 |
| Gross Profit | 4,317 | 4,628 | 9,099 | 5,625 | 5,727 |
| Operating Expenses | 2,478 | 3,658 | 3,864 | 2,129 | 2,228 |
| Operating Income | 1,839 | 969 | 5,235 | 3,496 | 3,499 |
| Other Income | 8,369 | -9,501 | -542 | 795 | 787 |
| Pre-tax Income | 10,208 | -8,531 | 4,692 | 4,291 | 4,286 |
| Income Tax | 701 | 157 | 1,804 | 1,344 | 1,377 |
| Net Income Continuous | 9,507 | -8,689 | 2,888 | 2,947 | 2,909 |
| Net Income | $9,507 | $-8,689 | $2,888 | $2,947 | $2,909 |
| EPS Basic Total Ops | 0.46 | -0.46 | 0.15 | 0.16 | 0.19 |
| EPS Basic Continuous Ops | 0.46 | -0.46 | 0.15 | 0.16 | 0.19 |
| EPS Diluted Total Ops | 0.46 | -0.46 | 0.15 | 0.16 | 0.19 |
| EPS Diluted Continuous Ops | 0.46 | -0.46 | 0.15 | 0.16 | 0.19 |
| EBITDA(a) | $4,297 | $4,628 | $9,099 | $5,625 | $5,727 |